Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

China flag China · Delayed Price · Currency is CNY
7.72
+0.13 (1.71%)
At close: Mar 10, 2026
7.37%
Market Cap 6.41B
Revenue (ttm) 1.45B
Net Income (ttm) 224.79M
Shares Out 829.67M
EPS (ttm) 0.27
PE Ratio 28.14
Forward PE n/a
Dividend 0.08 (1.03%)
Ex-Dividend Date Jun 6, 2025
Volume 11,480,400
Average Volume 15,814,000
Open 7.65
Previous Close 7.59
Day's Range 7.60 - 7.73
52-Week Range 6.35 - 8.41
Beta 0.13
RSI 53.30
Earnings Date Apr 23, 2026

About SHE:002349

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China. [Read more]

Sector Healthcare
Founded 1957
Employees 1,490
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002349
Full Company Profile

Financial Performance

In 2024, SHE:002349's revenue was 1.40 billion, a decrease of -7.25% compared to the previous year's 1.51 billion. Earnings were 212.65 million, a decrease of -14.15%.

Financial Statements

News

There is no news available yet.